SINCE Friedreich's original description 1 of 6 cases of familial hereditary ataxia in 1863, numerous papers have been written on this subject. The vast majority of these elaborate on the ...

Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced significant progress in its nomlabofusp program for Friedreich’s ...

Anthony Monaco was a very active teen—involved in soccer, wrestling, and even cross country—but he always felt a little awkward physically. It started with running a little differently than the kids ...

The Families for Friedreich’s Ataxia Foundation is grateful for the incredible support from Chelsea and the surrounding communities. On March 1st, the foundation hosted its very first fundraiser at ...

Health Canada has granted approval for Biogen’s Skyclarys (omaveloxolone) to treat Friedreich’s ataxia (FA), a rare, ...

Dunlavin was alive with the sounds of music and song when the community came together at St Nicholas Church of Ireland for a ...

In addition, I think the recognition across all diseases where not everyone is going to be an expert in FA, and people can refer readily to tertiary care centers and even ordinary care centers that ...

Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...

At this point, there are several therapies which are coming along, a large trial called the ExRx trial, which included the nutraceutical, nicotinamide riboside has finished. The data are not yet ...

PTC's diversified pipeline, including vatiquinone for Friedreich's ataxia, could significantly enhance revenue if approved, targeting a $2.8 billion market. Financial risks remain due to reliance ...

When he was 19, he was halfway through a tattoo apprenticeship when he was diagnosed with Friedreich's Ataxia (FA)—a degenerative neuromuscular disorder that's debilitating and life-shortening.